Monitoring cancer patients receiving outpatient treatment using a digital platform
Remote Monitoring of Cancer Patients with Outpatient Treatment
This study tests whether a digital app can help cancer patients track their symptoms and treatment while they receive care at home.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 34 (estimated) |
| Sex | All |
| Sponsor | Persei Vivarium Academic / other |
| Locations | 1 site (Madrid) |
| Trial ID | NCT06745401 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the usability of the Caaring® digital platform for monitoring cancer patients undergoing outpatient oral treatment. Participants will use the app to report on symptoms, treatment adherence, quality of life, and physical activity between medical visits. The findings will help inform future comparative studies to assess the benefits of this digital monitoring approach in managing cancer care.
Who should consider this trial
Good fit: Ideal candidates include cancer patients receiving adjuvant or metastatic oral treatment who can use a smartphone app and complete questionnaires.
Not a fit: Patients who lack the technological skills to use the app or cannot commit to follow-ups may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the management of cancer patients by providing real-time insights into their treatment experience and adherence.
How similar studies have performed: Other studies have shown promise in using digital platforms for patient monitoring, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cancer patients with adjuvant or metastatic oncological treatment * Cancer patients with oral oncological treatment * Patients who are able to complete the study questionnaires * Patients who are able to handle the application on a smart mobile phone. * Informed consent is obtained from the patient. Exclusion Criteria: * Patients who will not be able to commit to carrying out the follow-ups or do not have adequate technological skills. * Patients with inability to give adequately the informed consent.
Where this trial is running
Madrid
- Hospital HM Sanchinarro — Madrid, Spain (Recruiting)
Study contacts
- Study coordinator: Patricia Dominguez
- Email: patricia.dominguez@perseivivarium.com
- Phone: +34 915 004 013
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.